Advanced Search
Contact | Corporate | Help

A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

Sponsors:
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
RUMBA
  • Rheumatoid Arthritis
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: folate
  • Drug: methotrexate
  • Drug: methylprednisolone
  • Drug: placebo
  • Drug: rituximab
Enrollment:
40

Additional information about NCT00243412.


SourceSolution © 2008-2012